PVM-led Research on the Blood-Brain Barrier Featured on Cover of Scientific Journal

November 15, 2019

Dr. Lyle pictured against a photo backdrop holding a model of a brain — Dr. Tiffany Lyle, assistant professor of veterinary anatomic pathology at Purdue University, led research that has provided the first comprehensive characterization of both the blood-brain and blood-tumor barriers in brain metastases of lung cancer, which will serve as a road map for treatment development. (Purdue University photo/Rebecca Wilcox)

The most recently published research by the Comparative Blood-Brain Barrier Laboratory (CBBBL) in Purdue Veterinary Medicine’s Department of Comparative Pathobiology, was featured on the cover of Oncotarget, a peer-reviewed bio-medical journal. Dr. Gozde Uzunalli, postdoctoral research associate, was the first author of the article, which highlighted how the blood-brain barrier transitions into the blood-tumor barrier when it is disturbed by cancer cells. “We hope to be able use these results to increase drug delivery to metastatic brain lesions,” said Dr. Uzunalli, who has received two postdoctoral awards for her work at the CBBBL.

The research was led by Dr. Tiffany Lyle, assistant professor of veterinary anatomic pathology, whose work focuses on the pathology of the blood-brain barrier. As the principal investigator of the Comparative Blood-Brain Barrier Laboratory, she and her team have collaborated with other scientists at Purdue as well as the Indiana University Simon Cancer Center.

Cover of Oncotarget journal pictured — Research conducted in Purdue Veterinary Medicine’s Comparative Blood-Brain Barrier Laboratory gained great visibility when it was published as the cover article in the most recent issue (Issue 59) of Oncotarget, a peer-reviewed bio-medical journal.

The CBBBL research has provided the first comprehensive characterization of both the blood-brain and blood-tumor barriers in brain metastases of lung cancer, which will serve as a road map for treatment development. “Brain metastases occur most frequently in patients diagnosed with breast and lung cancer and melanoma,” Dr. Lyle said. “These metastases have a devastating survival rate, mostly because it’s so difficult to get drugs into the brain tissue because of the blood-brain barrier.”

The transition of the blood-brain barrier into the blood-tumor barrier presents a roadblock for effective drug delivery to the brain. The formation of the blood-tumor barrier has been insufficiently characterized in lung cancer until now, Dr. Lyle explained.

“We wanted to see what changes in the blood-brain barrier were occurring rapidly and which ones were sustained over time,” Dr. Lyle said. “Identifying those changes and pinpointing when they occur during the transition will be critical to developing treatment plans and being able to identify where, and when, cancer cells need to be targeted.”

Click here to read a complete news release about the research.

Writer(s): Maya Sanaba, PVM Communications Intern, and Abby Nickel, Purdue News Service | pvmnews@purdue.edu

Recent Stories

“Paws Up” for Jennifer Danaher – brought to you by the PVM Wellness Committee

This week we express our gratitude to Jennifer Danaher, who is department secretary for Veterinary Clinical Sciences.

‘Purdue Pursuits’: A PVM angle on Purdue’s teaching and learning reading groups

Crafting meaningful and engaging course experiences has been at the top of Dielson Vieira’s mind ever since he joined the Purdue University College of Veterinary Medicine’s faculty in 2024. As a clinical assistant professor in the Department of Basic Medical Sciences, Vieira is already adept at applying innovative teaching practices to classroom environments, but that doesn’t stop him from seeking out new ideas, approaches and perspectives — insights he gains through outlets like Purdue’s teaching and learning reading groups.

Top tier biology journal publishes PVM study that unlocks secrets of a drug-resistant fungal pathogen, which causes serious infections in humans

Though the name “Candida auris” is far from a household term, public health experts know it well because the multi-drug-resistant fungal pathogen, which causes serious human infections, has been classified as an urgent threat by the U.S. Centers for Disease Control and Prevention (CDC) Antibiotic Threats Report (2019). Dr. Shankar Thangamani, Associate Professor of Microbiology and University Faculty Scholar in the Purdue University College of Veterinary Medicine’s Department of Comparative Pathobiology, is researching C. auris, aided by a 2.4 million grant from the National Institutes of Health (NIH). New research findings, just published in Nature Microbiology, show how C. auris adapts and evades the immune system.

In Print: ‘Translational Research Methods for Tauopathies’

A just-published 300-page volume edited by Jessica Fortin, Purdue assistant professor in the College of Veterinary Medicine’s Department of Basic Medical Sciences, provides a significant new resource for researchers studying a group of neurodegenerative diseases known as tauopathies. “Translational Research Methods for Tauopathies” provides detailed protocols intentionally selected to serve as a basis for research laboratories seeking to further treatments for such debilitating neurodegenerative diseases as Alzheimer’s and chronic traumatic encephalopathy (CTE).

It’s Almost Here!

Though the annual Purdue Veterinary Conference is almost upon us, there’s still time to register and take advantage of this time-honored College of Veterinary Medicine fall tradition that combines excellent continuing education with fun opportunities for reconnecting with colleagues and classmates, networking, and learning about the latest veterinary trends and products. The 2026 Purdue Veterinary Conference takes place September 23–26 on the Purdue University campus. The annual event has something for everyone, from veterinarians to veterinary technicians, faculty, staff and students.